Experiencia
Habitual consultor de referencia, durante mi larga vida profesional, mi objetivo ha sido claramente proteger y respetar la salud y los derechos de las madres y niños. He puesto especial énfasis en la Neonatología, Enfermedades propias del lactante , Infecciones Respiratorias en especial Bronquiolitis , Infección por Virus Respiratorio Sincitial y sibilantes de repetición áreas en la que he sido ponente en mas de 25 países.
ver más
Especialista en:
- Infectología Pediátrica
- Neonatología
- Neumología Pediátrica
- Atención Primaria
Experiencia
Xavier Carbonell-Estrany
Pediatra
Enfermedades tratadas
- Asma pediátrico
- Bronquiolitis
- Dermatitis atópica
- Trastorno de alimentación en la lactancia y en la primera infancia
- Bebé prematuro
- Alergias respiratorias
- Reflujo en los bebés
- Cólico infantil
- Enfermedades Infecciosas en la infancia
Experiencia
- Universidad de Barcelona
- Instituto de Puericultura Maternidad de Barcelona
- Childrens Memorial Hospital Oklahoma .USA
- Childrens Hospital de Denver Colorado USA
- Cap de Servei de Neonatologia Hospital Clinic durant 22 anys
Publicaciones
- Carbonell X, Botet F, Figueras J, Álvarez E, Riu A. The incidence of breastfeeding in our environment. J. Perinat. Med 1998;26:320-324.
- Carbonell X, Guiffré L, Kimmpen Sletal.Guidelines for the use of Palivizumab in prevention of RSV disease. Infections in Medecine; December 1999.in infant.
- Carbonell X, Quero J, Bustos G et al. Rehospitalization due to respiratory syncytine vivus infection in premature infants under 33 week gestational age.A prospective study. Pediatrics Infectious Disease Journal 2000; 18: 592-597
- Barbara J. Law and Xavier Carbonell, MD, PhD.Epidemiology of respiratory syncytial virus disease.The Journal of Respiratory Disease; Vol. 2, NO. 4 Supplement, November 2000; 10-16
- Carbonell X, Botet F, Figueras, Riu A.Prediction of hyperbilirubinaemia in the healty term newborn.Acta Paediatrica, Feb 90 (2):
- J.Figueras, J Quero, X Carbonell-Estrany. Early administration of a second dose of surfactant in treatment of severe hyaline membrane disease. Acta Paediatrica, 2001:90:296-301.
- X Carbonell-Estrany, J Quero and the IRIS Study Group.Hospitalization rates for respiratory syncytial virus infection in premature infants born during two consecutive years. Pediatric Infectious Disease Journal. 2001;20:874-879.
- M.D. Salvia, L. García, A. Goncé, M.T. Esqué, J. Figueras, X. Carbonell.Convulsiones y hemorragia subaracnoidea tras exposición a paroxetina in utero.Rev. Neurol 2001; 33 () y Rev. Neurol 2003; 36 (8): 724-726.
- X Carbonell-Estrany, J Figueras.Anemia of Prematurity: treatment with erythropoietin. Review.Early Human Development 2002;65:S63-S67.
- B.J. Law, X. Carbonell-Estrany and E.A.F Simoes. An update on Respiratory Syncytial. Virus epidemiology : a developed country perspective.Respiratory Medecine March 2002; Vol. 96, Sup. B (SL).
- X. Carbonell and J. LL. Kimpen. RSV and RAD : posibilitéis for prevention. The link between respiratory syncytial virus and reactive airway disease.Respir Res 2002, 3 (suppl 1): S1-S2.
- J. Figueras, L. Gómez, J.M. Rodríguez-Miguélez, Y. Jordán, M.D. Salvia, W. Jiménez, X. Carbonell.Plasma nitrite/nitrate and endothelin-1 concentrations in neonatal.Acta Paediatr 92; .
- J. Figueras, Y. Jordán, J.M. Rodríguez-Miguélez, W. Jiménez, F. Botet, X. Carbonell, R. Jiménez.Expired Nitric Oxide in the Newborn with High Risk of Perinatal Infection.American Journal of Perinatology 2003, Vol. 20, Núm. 3
- E.A.F. Simoes, X. Carbonell.Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.Pediatr. Infect. Dis J. 2003; 22:S13-20.
- X. Carbonell. Palivizumab Outcomes Registry Data from Spain : Infección Respiratoria Infantil por Virus Respiratorio Sincitial (IRIS) Study Group. Pediatr. Infect. Dis J. 2003; 22:S55-7.
- López-Sastre JB, Coto GD, Fernández B, Carbonell FX , Figueras J .Neonatal invasive candidiasis: A prospective multicenter study of 118 cases.Am J Perinat 2003; 20:153-163.
- Pedraz C, Carbonell FX , Figueras J , Quero J.Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants.Pediatr Infect Dis J 2003; 22: 823-82
- Figueras-Aloy J, Gómez-López L, Rodríguez-Miguélez JM, Jordán-García Y, Salvia-Roigés MªD,Jiménez W, Carbonell-Estrany X.Plasma endothelin-1 and clinical manifestations of neonatal sepsis.
- Carbonell-Estrany X, Figueras-Aloy J and the Infección Respiratoria Infantil por Virus Respiratorio Sincitial Study Group, and J. Law B, MD and the Pediatric Investigators Collaborative Network on Infections in Canada Study Group.,Identitying Risk Factors for Severe Respiratory Syncytial Virus Among Infants Born After 33 Through 35 Completed Weeks of Gestation.The Pediatric Infectious Disease Journal 2004; 23, núm. 11: 1193-1201
- Vicente-Gutiérrez MP, Castelló-Almazán I, Salvia-Roigés MD, Rodríguez-Miguélez JM, Vives-Corrons MD, Figueras-Aloy J, Carbonell-Estrany X.Perinatal/Neonatal Case Presentation : Nonimmune Hydrops Fetalis due to Congenital Xerocytosis.Journal of Perinatology 2005; 25:63-65
- Carbonell Estrany, FX , Figueras Aloy J , Alvarez Domínguez E .Erythropoietin and prematurity - where do we stand?.J Perinat Med 2005; 33: 277-286. I.F.:0,79.
- Figueras J , Moro M, Pérez J, Fernández C, Roqués V, Quero J, Jiménez R , Carbonell FX .Antenatal Glucocorticoid Treatment Decreases Mortality and Chronic Lung Disease in Survivors among 23- to 28- Week Gestational Age Preterm Infants.Am J Perinat 2005; 22: 441-448. I.F.: 0,859.
- Pascual N, Herrero S, Salvia MD , Rodríguez-Miguélez JM , Figueras J , Carbonell FX .Repercusión fetal y neonatal del shock anafilático materno.Acta Pediatr Esp 2005; 63: 283-285.
- Alsina L, Esteban M, Salvia MD, Rodríguez-Miguélez JM, Figueras J, Carbonell X.Severe Hypernatremic Dehydration Secondary to Undetected Lactation Failure : Usefulness of Sodium Levels in Breast Milk.Clinical Pediatrics 2006;45:183-186
- Carbonell X. Coautor amb la Conselleria de Sanitat. Generalitat de Catalunya 2006.Protocol Hospitalari d'Assistència domiciliària per a nadons preterme o baix pes.Conselleria de Sanitat. Generalitat de Catalunya 2006.
- SimoesE, Carbonell-Estarny X.Palivizumab Prophylaxis, Respiratory Syncytial Virus and Subsequent Recurrent Wheezing.The Journal of Pediatrics August 2007
- Figueras J , Gómez L, Rodríguez-Miguélez JM , Salvia M , Jordán I, Ferrer I, Carbonell FX , Jiménez R.Serum Soluble ICAM-1, VCAM-1, L- Selectin, and P-Selectin Levels as Markers of Infection and their Relation to Clinical Severity in Neonatal Sepsis.Am J Perinat 2007; 24: 331-338.
- Coll O, Menendez C, Botet F, Dayal R, and the WAPM Perinatal Infections Working Group: Xavier Carbonell-Estrany, Leonard E, Weisman M, Anceschi M, Greenough A, Gibs R, Ville y. Treatment and prevention of malaria in pregnancy and newborn. J. Perinat. Med .
- Carbonell-Estrany X, Figueras J, Salcedo S, De la Rosa M, Castrillo Study Group.Probable early-onset group B streptococcal neonatal sepsis: a serious clinical condition related to intrauterine infection.Arch. Dis Chile Fetal Neonatal. Ed 2008, 93: F85-F89.
- Coll O, Menendez C, Botet F, Dayal R; World Association of Perinatal Medicine Perinatal Infections Working Group, Carbonell-Estrany X, Weisman LE, Anceschi MM, Greenough A, Gibss RS, Ville Y.Treatment and prevention of malaria in pregnancy and newborn.J Perinat Med. 2008;36(1):15-29.PMID: 18184095
- Management of jaundice and prevention of severe neonatal hyperbilirubinemia in infants >or=35 weeks gestation.Bhutani VK, Maisels MJ, Stark AR, Buonocore G; Expert Committee for Severe Neonatal Hyperbilirubinemia; European Society for Pediatric Research; American Academy of Pediatrics.Neonatology. 2008;94(1):63-7. Epub 2008 Jan 17
- Sampalis JS, Langley J, Carbonell-Estrany X, Paes B, O'Brien K, Allen U, Mitchell I, Aloy JF, Pedraz C, Michaliszyn AF.Development and validation of a risk scoring tool to predict respiratory syncytial virus hospitalization in premature infants born at 33 through 35 completed weeks of gestation.Med Decis Making. 2008 Jul-Aug;28(4):471-80. Epub 2008 Jun 12
- Miracle X, Di Renzo GC, Stark A, Fanaroff A, Carbonell-Estrany X, Saling E; Coordinators Of World. Associatin of Perinatal Medicine Prematurity Working Group.Guideline for the use of antenatal corticosteroids for fetal maturation.J Perinat Med. 2008;36(3):191-6.
- Carbonell-Estrany X, Bont L, Doering G, Gouyon JB, Lanari M.Clinical relevance of prevention of respiratory syncytial virus lower respiratory tract infection in preterm infants born between 33 and 35 weeks gestational age.Eur J Clin Microbiol Infect Dis. 2008 Oct;27(10):891-9. Epub 2008 Jul 16. Review
- Figueras-Aloy J, Carbonell-Estrany X, Quero-Jiménez J, Fernández-Colomer B, Guzmán-Cabañas J, Echaniz-Urcelay I, Doménech-Martínez E; IRIS Study Group FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks.
- Figueras-Aloy J, Berrueco R, Salvia-Roiges MD, Rodríguez-Miguélez JM, Miracle-Echegoyen X, Botet-Mussons F, Mur-Sierra A, Vall O, Carbonell-Estrany X.Attempt to normalize simulated exhaled nitric oxide according to ventilatory settings.Pediatr Pulmonol. 2008 Dec;43(12):1167-74.
- Simões EA, Carbonell-Estrany X, Fullarton JR, Liese JG, Figueras-Aloy J, Doering G, Guzman J; European RSV Risk Factor Study Group.A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33-35 weeks of gestational age, based on data from the Spanish FLIP StudyRespir Res. 2008 Dec 8;9:78.
- Figueras-Aloy J, Quero-Jiménez J, Fernández-Colomer B, Guzmán-Cabañas J, Echaniz-Urcelay I, Doménech-Martínez E; Grupo IRIS.Usefulness of different risk factor associations in predicting admissions due to respiratory syncytial virus in premature newborns of 32 to 35 weeks gestation in Spain.An Pediatr (Barc). 2009 Jul;71(1):47-53. Epub 2009 Jun 12. Spanish.
- Carbonell-Estrany X, Lázaro y de Mercado P.Health economics and RSV.Paediatr Respir Rev. 2009 Jun;10 Suppl 1:12-3. Review.
- Coll O, Benoist G, Ville Y, Weisman LE, Botet F, Anceschi MM, Greenough A, Gibbs RS, Carbonell-Estrany X; WAPM Perinatal Infections Working Group.Guidelines on CMV congenital infection.J Perinat Med. 2009;37(5):433-45
- Figueras-Aloy J, Rodríguez-Miguélez JM, Iriondo-Sanz M, Salvia-Roiges MD, Botet-Mussons F, Carbonell-Estrany X.Intravenous immunoglobulin and necrotizing enterocolitis in newborns with hemolytic disease.Pediatrics. 2010 Jan;125(1):139-44. Epub 2009 Nov 30.
- Carbonell-Estrany X, Simões EA, Dagan R, Hall CB, Harris B, Hultquist M, Connor EM, Losonsky GA; Motavizumab Study Group.Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial.Pediatrics. 2010 Jan;125(1):e35-51. Epub 2009 Dec 14
- Stensballe LG, Fullarton JR, Carbonell-Estrany X, Simões EA.POPULATION BASED EXTERNAL VALIDATION OF A EUROPEAN PREDICTIVE MODEL FOR RESPIRATORY SYNCYTIAL VIRUS HOSPITALIZATION OF PREMATURE INFANTS BORN 33 TO 35 WEEKS OF GESTATIONAL AGE.
- Arca G, Botet F, Palacio M, Carbonell-Estrany X.Timing of umbilical cord clamping: New thoughts on an old discussion.J Matern Fetal Neonatal Med. 2010 Jan 11. [Epub ahead of print]
- Botet F, Figueras J, Carbonell-Estrany X, Arca G, The Castrillo Study Group.Effect of maternal clinical chorioamnionitis on neonatal morbidity in very-low birthweight infants: a case-control study.J Perinat Med. 2010 Feb 2.
- Carbonell-Estrany X, Simões EA, Fullarton JR, Ferdynus C, Gouyon JB. Validation of a model to predict hospitalization due to RSV of infants born at 33-35 weeks' gestation.J Perinat Med. 2010 Mar 18. [Epub ahead of print]
- Simões EA, Carbonell-Estrany X, Fullarton JR, Rossi GA, Barberi I, Lanari M; European RSV Risk Factor Study Group.European risk factors' model to predict hospitalization of premature infants born 33-35 weeks' gestational age with respiratory syncytial virus: validation with Italian data.J Matern Fetal Neonatal Med. 2011 Jan;24(1):152-7. doi: Epub 2010 May 21.Reviewer last years 2003-2009
- Figueras Aloy J, Carbonell Estrany X; Comité de Estándares de la Sociedad Española de Neonatología.Recommendations for the use of palivizumab in the prevention of respiratory syncytial virus infection in late preterm infants (32(1) to 35(0) weeks of gestation).An Pediatr (Barc). 2010 Aug;73(2):98.e1-4. doi: 10.1016/j.anpedi Epub 2010 Jul 10.Spanish
- Simões EA, Carbonell-Estrany X, Rieger CH, Mitchell I, Fredrick L, Groothuis JR; Palivizumab Long-Term Respiratory Outcomes Study Group.The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children..J Allergy Clin Immunol. 2010 Aug;126(2):256-62. doi: 10.1016/j.jaci Epub 2010 Jul 10
- Moltó-Puigmartí C, Castellote AI, Carbonell-Estrany X, López-Sabater MC.Differences in fat content and fatty acid proportions among colostrum, transitional, and mature milk from women delivering very preterm, preterm, and term infants.Clin Nutr. 2011 Feb;30(1):116-23. doi: 10.1016/j.clnu Epub 2010 Aug 25
- Alvarez Domínguez E, Pérez Fernández JM, Figueras Aloy J, Carbonell Estrany X.Erythropoietin treatment for late anaemia after haemolytic disease of the newborn.An Pediatr (Barc). 2010 Dec;73(6):334-9. doi: 10.1016/j.anpedi Epub 2010 Oct 20.
- Figueras-Aloy J, Salvia-Roiges MD, Rodriguez-Miguélez JM, Miracle-Echegoyen X, Botet-Mussons F, Marín-Soria JL, Carbonell-Estrany X.Impact of chorioamnionitis on exhaled nitric oxide and endotracheal aspirate levels of nitrites-nitrates and interleukin-8 in mechanically ventilated preterm neonates.Pediatr Pulmonol. 2011 Jun;46(6):595-603. doi: 10.1002/ppul.21410. Epub 2011 Jan 18.
- Botet F, Figueras J, Carbonell-Estrany X, Narbona E.The impact of clinical maternal chorioamnionitis on neurological and psychological sequelae in very-low-birth weight infants: a case-control study.J Perinat Med. 2011 Mar;39(2):203-8. doi: 10.1515/JPM.2011.005. Epub 2011 Feb 7
- Costa-Orvay JA, Figueras-Aloy J, Romera G, Closa-Monasterolo R, Carbonell-Estrany X.The effects of varying protein and energy intakes on the growth and body composition of very low birth weight infants.
- Manzoni P, Paes B, Resch B, Carbonell-Estrany X, Bont L.High risk for RSV bronchiolitis in late preterms and selected infants affected by rare disorders: a dilemma of specific prevention.Early Hum Dev. 2012 May;88 Suppl 2:S34-41. doi: . Erratum in: Early Hum Dev. 2012 Oct;88(10):845. Mejias, A [removed]; Ramilo, O [removed]
- Botet F, Figueras-Aloy J, Miracle-Echegoyen X, Rodríguez-Miguélez JM, Salvia-Roiges MD, Carbonell-Estrany X.Trends in survival among extremely-low-birth-weight infants (less than 1000 g) without significant bronchopulmonary dysplasia.BMC Pediatr. 2012 Jun 8;12:63. doi: -12-63
- Carbonell-Estrany X, Fullarton JR, Gooch KL, Vo PG, Figueras-Aloy J, Lanari M, Gouyon JB, Liese JG.Effects of parental and household smoking on the risk of respiratory syncytial virus (RSV) hospitalisation in late-preterm infants and the potential impact of RSV prophylaxis.J Matern Fetal Neonatal Med. 2013 Jun;26(9):926-31. doi: Epub 2013 Feb 12
- Carbonell-Estrany X, Fullarton JR, Rodgers-Gray BS, Gooch KL, Vo PG, Figueras-Aloy J.Can we improve the targeting of respiratory syncytial virus (RSV) prophylaxis in infants born 32-35 weeks' gestational age with more informed use of risk factors?J Matern Fetal Neonatal Med. 2014 Aug 14:1-9. ;http://informahealthcare.com/jmf ; ISSN: 1476-7058 (print),1476-4954 (electronic)
- Alvarez Miró R, Lluch Canut MT, Figueras Aloy J, Esqué Ruiz MT, Arroyo Gili L, Bella Rodríguez J, Carbonell Estrany X.[Influence of in-home nursing care on the weight of the early discharged preterm newborn.]An Pediatr (Barc). 2014 Feb 27. pii: 00428-1. doi: 10.1016/j.anpedi Epub ahead of print] Spanish
- Di Renzo GC, Meli P, Beyardi A, Blennow M, Carbonell-Estrany X, Donzelli GP,Hakansson S, Hod M, Hughes R, Kurtzer M, Poyart C, Shinwel E, Stray-Pedersen B,Wielgos M, El Helali N.Intrapartum GBS screening and antibiotic prophylaxis:a European consensus conference.
- Carbonell-Estrany X. Parental and Family Burden of Respiratory Syncytial Virus (RSV) Infections- Xavier .Cure&Care: Journal of Neonatal Intensive Care Jan 5, 2015
- Figueras Aloy J, Carbonell Estrany X [Update of recommendations on the use of palivizumab as prophylaxis in RSV infections]. Comité de Estándares de la SENeo.An Pediatr (Barc). 2015 Mar;82(3):199.e1-2. doi:10.1016/j.anpedi Epub 2014 Nov 11. Spanish
- Carbonell-Estrany X, Pérez-Yarza EG, García LS, Guzmán Cabañas JM, Bòria EV, Atienza BB; IRIS Long-Term Burden and Respiratory Effects of Respiratory Syncytial Virus Hospitalization in Preterm Infants-The SPRING Study.(Infección Respiratoria Infantil por Virus Respiratorio Sincitial) Study Group.PLoS One. 2015.May 8;10(5):e0125422. doi: 10.1371/journal.pone.0125422. eCollection 2015
- Simoes EA, Carbonell-Estrany X, Guilbert T, Mansbach JM, Piedra PA, Ramilo O, Welliver R Sr. Clinical Endpoints for Respiratory Syncytial Virus Prophylaxis Trials in Infants and Children in High and Middle Income Countries.Pediatr Infect Dis J. 2015 Jun 26
- Figueras-Aloy J, Manzoni P, Paes B, Simões EA, Bont L, Checchia PA, Fauroux B, Carbonell-Estrany X.Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart Disease. Infect Dis Ther. 2016 Sep 14.
- Bont L, Checchia PA, Fauroux B, Figueras-Aloy J, Manzoni P, Paes B, Simões EA, Carbonell-Estrany X. Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries.Infect Dis Ther. 2016 Sep;5(3):271-98.
- Carbonell-Estrany X, Fullarton JR, Gooch KL, Gouyon JB, Lanari M, Rodgers-Gray BS, Thwaites RJ, Vo PG, Liese JG. The influence of birth weight amongst 33-35 weeks gestational age (wGA) infants on the risk of respiratory syncytial virus (RSV) hospitalisation: a pooled analysis.J Matern Fetal Neonatal Med. 2016
- Figueras Aloy J, Esqué Ruiz MT, Arroyo Gili L, Bella Rodriguez J, Álvarez Miró R, Carbonell Estrany X. [Changes in homecare for preterm and low-birth-weight infants from 2002 to 2014]. An Pediatr (Barc). 2016
- Checchia PA, Paes B, Bont L, Manzoni P, Simões EA, Fauroux B, Figueras-Aloy J, Carbonell-Estrany X. Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Congenital Heart Disease. Infect Dis Ther. 2017 Mar;6(
- Paes B, Fauroux B, Figueras-Aloy J, Bont L, Checchia PA, Simões EA, Manzoni P, Carbonell-Estrany X Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus infection Among Infants with Chronic Lung Disease. Infect Dis Ther. 2016
- Anderson EJ, Carbonell-Estrany X, Blanken M, Lanari M, Sheridan-Pereira M, Rodgers-Gray B, Fullarton J, Rouffiac E, Vo P, Notario G, Campbell F, Paes B Burden of Severe Respiratory Syncytial Virus Disease Among 33-35 Weeks' Gestational Age Infants Born During Multiple Respiratory Syncytial Virus Seasons. Pediatr Infect Dis J. 2017
- Manzoni P, Figueras-Aloy J, Simões EAF, Checchia PA, Fauroux B, Bont L, Paes B, Carbonell-Estrany X. Defining the Incidence and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Children with Chronic Diseases. Infect Dis Ther. 2017
- Sanchez-Luna M, Burgos-Pol R, Oyagüez I, Figueras-Aloy J, Sánchez-Solís M, Martinón-Torres F, Carbonell-Estrany X. Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: update based on the clinical evidence in Spain. BMC Infect Dis. 2017
- Fauroux B, Simões EAF, Checchia PA, Paes B, Figueras-Aloy J, Manzoni P, Bont L, Carbonell-Estrany X. The Burden and Long-term Respiratory Morbidity Associated with Respiratory Syncytial Virus Infection in Early Childhood. Infect Dis Ther. 2017
- Blanken MO, Paes B, Anderson EJ, Lanari M, Sheridan-Pereira M, Buchan S, Fullarton JR, Grubb E, Notario G, Rodgers-Gray BS, Carbonell-Estrany X. Risk scoring tool to predict respiratory syncytial virus hospitalisation in premature infants. Pediatr Pulmonol. 2018
- Simões EAF, Bont L, Manzoni P, Fauroux B, Paes B, Figueras-Aloy J, Checchia PA, Carbonell-Estrany X.UI Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children. Infect Dis Ther. 2018
- Carbonell-Estrany X, Dall'Agnola A, Fullarton JR, Rodgers-Gray BS, Girardi E, Mussa A, Paniagua N, Pieretto M, Rodríguez-Fernandez R, Manzoni P. Interaction between healthcare professionals and parents is a key determinant of parental distress during childhood hospitalisation for respiratory syncytial virus infection (European RSV Outcomes Study [EROS]). Acta Paediatr. 2018
- Luna MS, Manzoni P, Paes B, Baraldi E, Cossey V, Kugelman A, Chawla R, Dotta A, Fernández RR, Resch B, Carbonell-Estrany X Expert consensus on palivizumab use for respiratory syncytial virus in developed countries. Paediatr Respir Rev. 2018
- Carbonell-Estrany X RSV prevention in infancy and asthma in later life. Lancet Respir Med. 2018
- Paes B, Carbonell-Estrany X Respiratory syncytial virus prophylaxis for children with chronic lung disease: have we got the criteria right? Expert Rev Anti Infect Ther. 2019
Formación
- Titulo de médico Universidad Barcelona en 1968 y posteriormente Doctorado en el año 1990. Dr. Carbonell ha estado involucrado en la atención perinatal desde 1969
- Ha ocupado el cargo de Jefe del Servicio de Neonatología del Hospital Clínic - Maternitat , Institut Clínic de Ginecologia , Obstetricia Neonatologia en Barcelona hasta 2008
- Consultor Senior del Servicio de Neonatología del Hospital Clínic
- Vice - Presidente de la Sociedad Española de Neonatología 2003-2007
- Miembro de la Junta de la Asociación Mundial de Medicina Perinatal ( WAPM ) .
- Miembro de la Junta de la Sociedad The Fetus as a Patient
- Miembro de la Junta de la European Asociation of Perinatal Medicine ( EAPM )
- Miembro titular de la International Academy of Perinatal Medicine
- Presidente de la World Association of Perinatal Medicine ( WAPM )
- Vice Presidente de Matres Mundi Internacional
Premios y distinciones
- Miembro de honor de la Mexican neonatal Society
- Miembro de honor de la Egypt Perinatal Society
- Miembro de honor de la Croatian Perinatal Society
- Miembro de honor de la Spanish Neonatal Society
- Miembro de honor de laRussian Perinatal Society
- Galardonado con la medalla de Medicina Perinatal Sir William Liley
- Erich Sailing Perinatal Prize 2015
Consulta
Este especialista no ofrece reserva online en esta dirección
Atiende a:
niños de cualquier edad
Primera visita Pediatría • 120 €
Visitas sucesivas Pediatría • 100 €
Control pediátrico • 100 € +3 ver más
¿Este especialista no dispone de la información que necesitas?
Mostrar otros pediatras cerca de míPronto se publicarán opiniones
Escribe la primera opinión
¿Te has visitado con Dr. Xavier Carbonell-Estrany? Comparte cómo fue tu experiencia. Cientos de pacientes te lo agradecerán.
Añadir tu opiniónPreguntas frecuentes
-
¿Cuáles son las principales especialidades de Xavier Carbonell-Estrany?Xavier Carbonell-Estrany es pediatra. Te mostramos algunos de los servicios que ofrece gracias a su trayectoria y amplia experiencia: Primera visita Pediatría, Control pediátrico, Revisión pediátrica, Visita de revisión, Visitas sucesivas Pediatría, Segundas opiniones.
-
¿Dónde está la consulta de Xavier Carbonell-Estrany?Xavier Carbonell-Estrany atiende a sus pacientes en:
- C/ d´Anglí, 59 Barcelona
-
¿Puedo hacer la visita con Xavier Carbonell-Estrany de forma online, sin tener que desplazarme hasta su consulta?No, por el momento Xavier Carbonell-Estrany no ofrece consulta online.
-
¿Cómo se realiza el pago a Xavier Carbonell-Estrany al finalizar la visita?Xavier Carbonell-Estrany acepta los siguientes métodos de pago: Efectivo.
-
¿Qué idiomas habla Xavier Carbonell-Estrany?Puedes comunicarte con Xavier Carbonell-Estrany en Español, Catalán, Inglés, Francés.
-
¿Cómo puedo reservar una cita con Xavier Carbonell-Estrany?En esta dirección Xavier Carbonell-Estrany aún no ha indicado qué horas tiene disponibles. Te recomendamos que contactes con Xavier Carbonell-Estrany directamente para que te indique qué huecos tiene en su agenda.
-
¿Para cuándo podría visitarme con Xavier Carbonell-Estrany?Contacta directamente con Xavier Carbonell-Estrany para ver cuál es su disponibilidad.
-
¿Qué aseguradoras acepta Xavier Carbonell-Estrany?Xavier Carbonell-Estrany no acepta aseguradoras, sólo pacientes privados. Te recomendamos que, en caso de duda, te pongas en contacto con el especialista.
Pediatras cercanos
Enfermedades más tratadas
Dermatitis atópica en Barcelona
Alergias respiratorias en Barcelona
Trastorno de alimentación en la lactancia y en la primera infancia en Barcelona
Trastorno de hiperactividad y déficit de atención (TDAH) en Barcelona
Reflujo en los bebés en Barcelona
Alergia alimentaria en Barcelona
Lesiones deportivas en Barcelona
Obesidad infantil en Barcelona
Cáncer colorrectal en Barcelona
Cáncer de próstata en Barcelona
Tendinitis del manguito de los rotadores en Barcelona
Ver más (15)
Aseguradoras más populares
Pediatras de Asistencia Sanitaria Colegial en Barcelona
Pediatras de Caser en Barcelona
Pediatras de Fiatc en Barcelona
Pediatras de Sanitas en Barcelona
Pediatras de Adeslas en Barcelona
Pediatras de DKV Seguros en Barcelona
Pediatras de HNA - Hermandad Arquitectos en Barcelona
Pediatras de Asisa en Barcelona
Pediatras de Agrupación Mutua en Barcelona
Pediatras de Mapfre en Barcelona
Pediatras de Cigna Healthcare España en Barcelona
Pediatras de Aegon Salud en Barcelona
Pediatras de Divina Pastora en Barcelona
Pediatras de Generali Seguros en Barcelona
Pediatras de Allianz en Barcelona
Pediatras de Clinicum Seguros en Barcelona
Pediatras de Mutua Manresana en Barcelona
Pediatras de Vital Seguro en Barcelona
Ver más (15)